Fate Therapeutics, Inc. (FATE) vs Invivyd, Inc. (IVVD)
Fate Therapeutics, Inc. and Invivyd, Inc. are both Biotechnology companies. Fate Therapeutics, Inc. and Invivyd, Inc. are of similar size ($279.2M and $274.1M). Invivyd, Inc. grew revenue faster over the last twelve months: 26.3% against −23.4%. Invivyd, Inc. has the higher net margin (−183.9% vs −1,941.1%) and the lower return on invested capital (−334.9% vs 0.00%). Across the 16 metrics below, Invivyd, Inc. leads on 11 and Fate Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | FATE | IVVD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 92.23% | 65.16% |
| Operating margin | (2,058.08%) | (192.81%) | 0.00% |
| Net margin | (1,941.09%) | (183.90%) | 0.00% |
| Free cash flow margin | (1,624.06%) | (187.88%) | 0.00% |
| Return on equity | (60.75%) | (95.89%) | (57.72%) |
| Return on assets | (39.89%) | (69.69%) | (49.22%) |
| Return on invested capital | 0.00% | (334.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack